secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xenetic Biosciences, Inc. (XBIO)
CIK:        0001534525
Form:       8-K
Filed at:   2023-12-08T23:59:59+00:00
Accession:  0001683168-23-008731
Event type: other_material
Sentiment:  negative
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Xenetic Biosciences shareholders reject non-binding say-on-pay proposal at 2023 annual meeting
--------------------------------------------------------------------------------

- Nine director nominees elected; Dr. Dmitry Genkin received highest 'for' votes (461,413), Jeffrey Eisenberg lowest (255,632).
- Ratification of Marcum LLP as auditor approved with 804,522 for, 21,792 against.
- Say-on-pay advisory proposal failed: 153,605 for, 318,665 against, 2,112 abstained; received less than one-third of votes cast.
- Broker non-votes of 356,015 on director elections and say-on-pay due to routine/non-routine mix.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534525/000168316823008731/0001683168-23-008731-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534525/000168316823008731/xenetic_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-23-008731

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer